Search
Clinical Trials
Locally Advanced (NRG HN009)
Locally Advanced (NRG HN004) Temporarily on Hold
First Line or Neoadjuvant (NRG-HN005) Temporary Hold
Locally Advanced (RTOG 1216)
Targeted Therapy (ASCO TAPUR)
Featured Investigator
Deepti Behl
MD
Dr. Behl is a research physician at Sutter Institute for Medical Research (SIMR). Her research interests include Oncology research focusing on lung cancer.